Human CAMP/LL37/FALL39 Alexa Fluor® 700-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # AF7497N
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Leu134-Ser170
Accession # P49913
Specificity
Clonality
Host
Isotype
Applications for Human CAMP/LL37/FALL39 Alexa Fluor® 700-conjugated Antibody
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
Background: CAMP/LL37/FALL39
CAMP (Cathelicidin AntiMicrobial Peptide; also18 kDa cationic antimicrobial protein, CAP18, LL37, FALL39 and HSD26) is a member of the cathelicidin family of proteins. It is widely expressed, being found associated with neutrophils, bronchial epithelium, renal tubule epithelium, activated keratinocytes, gamma delta T cells, monocytes, NK cells, colonic epithelium and the stratum basale of nonkeratinized epithelium found in the vagina and oral cavity. CAMP has marked antimicrobial activity against both Gm+ and Gm- bacteria, and acts as a chemoattractant for neutrophils, monocytes and mast cells. CAMP is synthesized as 170 amino acid (aa) preproprecursor. It contains a 30 aa signal sequence, a 103 aa, 14 kDa prosegment (aa 31-131), and a 4-5 kDa, 37 aa (aa 134-170) C‑terminal mature fragment (LL37) or 39 aa (aa 132‑170) C‑terminal mature fragment (FALL39). In neutrophils, the 18-19 kDa proprecursor is stored in granules, where, upon activation, it is enzymatically cleaved and released. While both the prosegment and C‑terminal fragments possess antimicrobial activity, the prosegment also shows antiprotease activity, while the C‑terminal fragment also shows chemotactic activity. The prosegment may form homodimers, while the C‑terminal fragment (LL37) is reported to form homotetramers. Over aa 141-170, human CAMP shares only 50% and 57% aa sequence identity with mouse and rat CAMP, respectively.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional CAMP/LL37/FALL39 Products
Product Specific Notices for Human CAMP/LL37/FALL39 Alexa Fluor® 700-conjugated Antibody
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
For research use only